Literature DB >> 25296717

Quantitative and functional characteristics of endothelial progenitor cells in newly diagnosed hypertensive patients.

M Skrzypkowska1, J Myśliwska1, B Słomiński1, J Siebert2, P Gutknecht2, M Ryba-Stanisławowska1.   

Abstract

Populations of peripheral blood CD34(+) cells comprise precursors of endothelial cells. These precursors are crucial to cardiovascular homeostasis. Hypertension, as one of the main risk factors for cardiovascular disease, is associated with the loss of endothelium structural integrity and its functional impairment. The aim of our study was to evaluate the subsets of endothelial precursor cells in patients with newly diagnosed arterial hypertension. Twenty-four newly diagnosed, previously untreated hypertensive patients aged 59.5 ± 12.5 years, were enrolled into the study group, whereas the control group comprised 45 healthy subjects, 55.5±10.0 years old. Endothelial progenitor cells (EPCs) were analysed by flow cytometry. The results showed that hypertensive patients were characterized by a significantly higher percentage and number of the CD34(+) cells and simultaneously less differentiated CD34(+)CD45(dim/neg)CD133(+) progenitors. The percentage and number of CD34(+)CD45(neg)VEGFR2(+) and CD34(+)CD45(neg)CD133(+)VEGFR2(+) cells were not different from the control group. Moreover, patients had a significantly lower percentage and number of the CD34(+)CD45(neg)VEGFR2(+)CXCR4(+) and CD34(+)CD45(neg)VEGFR2(+)ICAM-1(+) cells than healthy individuals. These changes were paralleled by early symptoms of nephropathy, that is, lower glomerular filtration rate (GFR) values and borderline micro albuminuria. Our results indicate that an elevation in the number of less differentiated progenitors may be a mechanism compensating for defects of migration and adhesion, present in a more differentiated subset.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25296717     DOI: 10.1038/jhh.2014.85

Source DB:  PubMed          Journal:  J Hum Hypertens        ISSN: 0950-9240            Impact factor:   3.012


  32 in total

1.  Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.

Authors: 
Journal:  Circulation       Date:  2002-12-17       Impact factor: 29.690

2.  Endothelial progenitor cells in patients with essential hypertension.

Authors:  Pietro Delva; Maurizio Degan; Paola Vallerio; Enrico Arosio; Pietro Minuz; Gabriella Amen; Marzia Di Chio; Alessandro Lechi
Journal:  J Hypertens       Date:  2007-01       Impact factor: 4.844

3.  Circulating CD34(+) progenitor cell frequency is associated with clinical and genetic factors.

Authors:  Kenneth S Cohen; Susan Cheng; Martin G Larson; L Adrienne Cupples; Elizabeth L McCabe; Ying A Wang; Julius S Ngwa; Roderick P Martin; Rachael J Klein; Basma Hashmi; Yin Ge; Christopher J O'Donnell; Ramachandran S Vasan; Stanley Y Shaw; Thomas J Wang
Journal:  Blood       Date:  2013-01-03       Impact factor: 22.113

4.  Isolation of putative progenitor endothelial cells for angiogenesis.

Authors:  T Asahara; T Murohara; A Sullivan; M Silver; R van der Zee; T Li; B Witzenbichler; G Schatteman; J M Isner
Journal:  Science       Date:  1997-02-14       Impact factor: 47.728

5.  Circulating progenitor cells are increased in newly diagnosed untreated hypertensive patients with arterial stiffening but normal carotid intima-media thickness.

Authors:  Giuseppe Mandraffino; Maria A Sardo; Stefania Riggio; Saverio Loddo; Egidio Imbalzano; Angela Alibrandi; Carlo Saitta; Maurizio Cinquegrani; Enrico M Mormina; Antonino Saitta
Journal:  Hypertens Res       Date:  2011-05-19       Impact factor: 3.872

Review 6.  Endothelial dysfunction and oxidative stress in arterial hypertension.

Authors:  P Ferroni; S Basili; V Paoletti; G Davì
Journal:  Nutr Metab Cardiovasc Dis       Date:  2006-03-24       Impact factor: 4.222

Review 7.  Targeting endothelial dysfunction in hypertensive subjects.

Authors:  C Thuillez; V Richard
Journal:  J Hum Hypertens       Date:  2005-06       Impact factor: 3.012

8.  Structural skin capillary rarefaction in essential hypertension.

Authors:  T F Antonios; D R Singer; N D Markandu; P S Mortimer; G A MacGregor
Journal:  Hypertension       Date:  1999-04       Impact factor: 10.190

9.  Increased circulating activated endothelial cells, vascular endothelial growth factor, and tumor necrosis factor in thalassemia.

Authors:  Punnee Butthep; Saknarong Rummavas; Raewadee Wisedpanichkij; Sumalee Jindadamrongwech; Suthat Fucharoen; Ahnond Bunyaratvej
Journal:  Am J Hematol       Date:  2002-06       Impact factor: 10.047

10.  Human haemato-endothelial precursors: cord blood CD34+ cells produce haemogenic endothelium.

Authors:  Elvira Pelosi; Germana Castelli; Ines Martin-Padura; Veronica Bordoni; Simona Santoro; Alice Conigliaro; Anna Maria Cerio; Marco De Santis Puzzonia; Paola Marighetti; Mauro Biffoni; Tonino Alonzi; Laura Amicone; Myriam Alcalay; Francesco Bertolini; Ugo Testa; Marco Tripodi
Journal:  PLoS One       Date:  2012-12-04       Impact factor: 3.240

View more
  5 in total

1.  Preserved endothelial progenitor cell angiogenic activity in African American essential hypertensive patients.

Authors:  Seo Rin Kim; Alfonso Eirin; Sandra M S Herrmann; Ahmed Saad; Luis A Juncos; Amir Lerman; Stephen C Textor; Lilach O Lerman
Journal:  Nephrol Dial Transplant       Date:  2018-03-01       Impact factor: 5.992

2.  Involvement of NADPH oxidases and non-muscle myosin light chain in senescence of endothelial progenitor cells in hyperlipidemia.

Authors:  Ting-Bo Li; Jie-Jie Zhang; Bin Liu; Wei-Qi Liu; Yan Wu; Xiao-Ming Xiong; Xiu-Ju Luo; Qi-Lin Ma; Jun Peng
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2015-12-19       Impact factor: 3.000

3.  Association of circulating progenitor cells with angiotensin II in newly diagnosed hypertensive patients.

Authors:  Maria W Skrzypkowska; Monika E Ryba-Stanisławowska; Bartosz Słomiński; Piotr G Gutknecht; Janusz Siebert; Jolanta M Myśliwska
Journal:  J Hum Hypertens       Date:  2017-11-30       Impact factor: 3.012

4.  The GG genotype of the -152 G/A vascular endothelial growth factor (VEGF) polymorphism predisposes to hypertension-related chronic kidney disease.

Authors:  Anna Małkiewicz; Maria Skrzypkowska; Bartosz Słomiński; Janusz Siebert; Piotr Gutknecht; Jolanta Myśliwska
Journal:  Mol Biol Rep       Date:  2016-07-06       Impact factor: 2.316

5.  Pitavastatin nanoparticle-engineered endothelial progenitor cells repair injured vessels.

Authors:  Huanyun Liu; Pang Bao; Lufeng Li; Yuqing Wang; Chunxin Xu; Mengyang Deng; Jihang Zhang; Xiaohui Zhao
Journal:  Sci Rep       Date:  2017-12-22       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.